DRKS00028182已完成不适用
Prospective, multi-centre, non-interventional safety trial to collect real-world data on the safety of immunotherapy with Depigoid® Katze in patients with allergic rhinitis/rhino-conjunctivitis with or without controlled asthma due to feline epithelia - LETI MIAU-KAT 2022
ETI Pharma GmbH0 个研究点目标入组 102 人开始时间: 2022年3月14日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 102
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 12 Years 至 99 Years（—）
- 性别
- All
入选标准
- •Patients aged = 12 years suffering from persistent moderate to severe allergic rhinitis and/or rhino-conjunctivitis with or without controlled asthma caused by clinically relevant sensitisation to cats, demonstrated by a positive skin prick test (wheal diameter = 3 mm) for Felix domesticus animal epithelia.
- •The patients have an indication for subcutaneous immunotherapy based on their symptoms and findings and, together with their doctor, chose treatment with Depigoid® Katze in accordance with standard clinical practice.
- •The patients have understood and signed the declaration of consent form for participation and use of patient-related data in this non-interventional safety study.
- •Concomitant asthma must be under control and stable as per the guidelines in the SmPC (no exacerbations within 3 months prior to inclusion in the study).
排除标准
- •not applicable
研究者
相似试验
尚未招募
4 期
A Observational non-interventional Post Marketing Surveillance (PMS) Study of RituxiRelTM RN(Rituximab)in Patients with Pemphigus VulgarisCTRI/2020/06/025819Reliance Life Sciences Pv Ltd
尚未招募
4 期
A Non-interventional, observational Post Marketing Surveillance (PMS) Study of AdaliRelTM (Adalimumab) in Patients With Active Rheumatoid arthritis.CTRI/2020/04/024644Reliance Life Sciences Pv Ltd
招募中
4 期
A post marketing surveillance study to evaluate the safety and tolerability of Gaviscon Double Action Oral Suspension and Gaviscon Double Action Tablets in patients with Gastroesophageal Reflux DiseaseCTRI/2024/02/062711Reckitt Benckiser Healthcare
暂停
不适用
A NON-INTERVENTIONAL, MULTI-CENTER, NON?RANDOMISED PATIENT REGISTRY FOR POST?MARKETING SURVEILLANCE OF MULTIPLE ORGAN DIALYSISMultiple Organ FailureN17K72E87Acute renal failureHepatic failure, not elsewhere classifiedOther disorders of fluid, electrolyte and acid-base balanceDRKS00017068ADVITOS GmbH282
尚未招募
4 期
A research study to understand how oral semaglutide works in people with type 2 diabetes in IndiaCTRI/2023/02/049724ovo Nordisk AS